| The Trauma Research Program at Johnson City Medical Center focuses on patient care throughout the trauma care continuum in a rural setting, which includes injury prevention, pre-hospital intervention and resuscitation, operative and critical care management, and rehabilitation.
We collaborate with the Mountain States Health Alliance Corporate Department of Research and the East Tennessee State University Office for the Protection of Human Subjects (IRB), who facilitate and maintain oversight of our research endeavors. Clinical research is further governed by federal regulations administered by the Food and Drug Administration (FDA) and the Office of Human Research Protection (OHRP).
Investigator/faculty Initiated studies
Proposed:
- Characteristics of a Trauma Population Admitted to a Level 1 Trauma Center Serving Central and Southern Appalachia
- Functional NG Study
|
Industry Sponsored (multicenter) studies
 A closed head injury can occur due to a fall, motor vehicle crash, or any blunt force injury. Closed head injury, resulting in swelling and damage to the brain, is the leading cause of death and disability worldwide. This multicenter, global trial is investigating a medication made from a naturally occurring hormone that has been shown to reduce brain swelling and to 
protect the brain from further damage occurring after a traumatic injury. Results from this trial could be used to develop the first ever FDA approved drug for the treatment of traumatic brain injury.
 Our goal is to establish a strong foundation as a research leader
in both industry-sponsored and investigator-initiated research. As part
of our Performance Improvement and Patient Safety (PIPS) program, we
will identify and initiate research which focuses on the specific needs
of our regional population. Our Trauma Registry and medical library are invaluable tools in support of this goal.
New York Times Article: "An Hormonal Remedy for Brain Injuries Is Explored"
|